Genetic susceptibility to coronavirus to be tested in ground-breaking nationwide study Genomes of thousands of patients with coronavirus will be sequenced to understand how a person’s genetic makeup could influence how they react to the virus Genomics England partners with University of Edinburgh to lead research drive to support the search for new treatment Thousands […]
By disrupting the expression of a particular gene and observing how this change affects expression of other genes, researchers can learn about the cellular roles of the disrupted gene. New technologies such as Perturb-seq offer unprecedented detail and depth of insight from such genetic disruption studies, but technical and practical hurdles have limited use of […]
– KAPA HyperExome is a state-of-the-art whole exome research panel with improved performance over the on-market SeqCap portfolio, providing improved coverage and uniformity – The KAPA Target Enrichment portfolio empowers clinical researchers to process more samples successfully while optimizing sequencing efficiency – When linked with KAPA library prep, the portfolio can reduce turnaround time for […]
Aldevron Appoints James Brown, Ph.D. President of Research Grade Nucleic Acids Business Unit FARGO, N.D. — Aldevron, the leading plasmid DNA manufacturing company, has expanded its leadership team by appointing Dr. James Brown President of its Research Grade nucleic acids business unit. Dr. Brown will oversee Aldevron’s strategy to provide plasmids and other nucleic acids […]
Merck KGaA, Darmstadt, Germany today announced that two of its Life Science business’ CRISPR-assisted genome-editing patents have been allowed in the United States. Technology provides more tools to fight difficult-to-treat diseases Life Science business actively licensing its CRISPR-Cas9 technology for therapeutic and other uses Committed to ethical use of genome-editing technology Merck KGaA, Darmstadt, Germany, […]
SHANGHAI, China — Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are joining forces to promote the development and standardization of NGS-based cancer therapy selection in China based on Illumina’s NextSeqTM 550Dx system. In 2015, Illumina’s sequencing technology and Burning Rock’s development and commercial capabilities were for […]
Blue-Ray Biotech Corporation, a professional PCR instrument manufacturer, today releases its real-time PCR system, the TurboQ. Designed for multiplex PCR and routine detection with versatile features, TurboQ can greatly help bio-scientists and clinical lab practitioners in performing COVID-19 diagnostic testing and researches. Mr. Fed Chu, Sales Manager of Blue-Ray Biotech, explains why the company is […]
Mérieux Equity Partners and Korys announce the launch of a new investment platform in Venture Capital to support innovative companies in the healthcare and nutrition sectors, in Europe and North America. OMX Europe Venture Fund FPCI (“OMX Europe”) was launched with a significant financial commitment representing more than two thirds of the target size of […]
Company to provide 50 Ion Torrent Genexus Systems for consortia members at a subsidized price to support global COVID-19 research CARLSBAD, Calif. — To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific today announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the […]
Philadelphia-based Initiative Will Facilitate SARS-CoV-2 Research to Develop Antiviral Therapy for COVID-19 Using RNA Silencing FANA ASO Technology PHILADELPHIA — The coronavirus pandemic has significantly disrupted life in most countries around the globe, causing a severe health and economic crisis. AUM LifeTech, Inc., a preclinical stage biotech company developing RNA therapeutics, and AUM BioTech, LLC, […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
